A Study to Understand the Safety of the 20vPnC Vaccine in Healthy Chinese Adults, Children, and Infant

PHASE1RecruitingINTERVENTIONAL

Enrollment

100

Participants

Timeline

Start Date

June 15, 2025

Primary Completion Date

May 14, 2027

Study Completion Date

May 14, 2027

Conditions

Pneumococcal Disease

Interventions

BIOLOGICAL

20vPnC

20vPnC vaccine

Trial Locations (2)

RECRUITING

Guangxi Zhuang Autonomous Region Center for Disease Control and Prevention, Nanning

RECRUITING

Wuming District Center for Disease Control and Prevention, Chengxiang